Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

IL-1RAP Is a Targetable Surface Antigen in Relapsed/Refractoy AML

Blood (2024) 144 (Supplement 1): 4311.

https://doi.org/10.1182/blood-2024-199673

Published: 2024

Journal Articles

Resolve AML 001: An Adaptive Open-Label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of Cctx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients with r/r AML

Marion Subklewe, Nicolas Boissel, Stephan Mielke, Pere Barba, Elisa Sala, Eric Deconinck, Olivia Fiere, Jonathan Jaeger, Chloe Vasseghi, Marina Deschamps, Christophe Ferrand, Edouard De Dreuzy, Richard Sainson, Jens Hasskarl

Blood (2024) 144 (Supplement 1): 2883.2.

https://doi.org/10.1182/blood-2024-203204

Published: 2024

Journal Articles

A Fast and Accurate Cartridge-Based RT-qPCR Assay to Quantify PML-Rara mRNA Fusion Transcripts Near the Point of Care

Natalie Chi-hwa Wu, PhD, Monisha Malek, B.S., Ken Ho, B.S, Julia Chen, PhD, Anvita Komarla, B.S., Victor Chu, PhD, Huilin Wei, MD PhD, Gwo-Jen Day, PhD, Jean-Michel Cayuela, PhD, Christophe Ferrand, PhD, Bruno Cassinat, PharmD, PhD

Blood (2018) 132 (Supplement 1): 1481.

https://doi.org/10.1182/blood-2018-99-110111

Published: 2018

Journal Articles

Dynamic of Telomeric Parameters in Relapsing or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL), an Analysis of the Filo ICLL001 Bomp Trial

Blood (2017) 130 (Supplement 1): 4285.

https://doi.org/10.1182/blood.V130.Suppl_1.4285.4285

Published: 2017

Journal Articles

Optimal Whole Blood Storage Conditions for Measuring BCR-ABL1 Accurately for Xpert ® BCR-ABL Ultra

Gwo-Jen Day, PhD, Alba Levitas, Christophe Ferrand, PhD, Marina Deschamps, PhD, Krupa Shridhar, Sandy Huang, Brian Rhees, PhD, Michael P. Bates, MD, Wendy Wong, Jerald P. Radich, MD

Blood (2017) 130 (Supplement 1): 5256.

https://doi.org/10.1182/blood.V130.Suppl_1.5256.5256

Published: 2017

Journal Articles

Xpert ® BCR-ABL Ultra, a High Sensitivity Assay, Demonstrates a Limit of Detection Reaching MR4.5 and below

Christophe Ferrand, PhD, Marina Deschamps, PhD, Alba Levitas, Christina Lockwood, PhD, Jacqueline E. Payton, MDPhD, Geoffrey L. Uy, MD, Charles A. Schiffer, MD, Gerald Feldman, MD, Aaron Bossler, MD PhD, Julie Woolworth, PhD, Alice S. Mims, MD MSCR, Krupa Shridhar, Natalie Wu, PhD, Sandy Huang, Huilin Wei, MD PhD, Chris Lykke, PhD, Michael P. Bates, MD, Wendy Wong, Gwo-Jen Day, PhD

Blood (2017) 130 (Supplement 1): 1610.

https://doi.org/10.1182/blood.V130.Suppl_1.1610.1610

Published: 2017

Journal Articles

Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia

Cecile Bally, Jacqueline Lehmann-Che, Bruno Cassinat, PharmD, PhD, Lionel Ades, MD PhD, Eric Letouze, Pierre Hirsch, Marie-Joelle Mozziconacci, Sophie Raynaud, MD, Eric Delabesse, PharmD, PhD, Madalina Uzunov, MD, Mathilde Hunault, MD PhD, Eric Lippert, PhD, Hélène Lapillonne, MD PhD, Christophe Ferrand, PhD, Carine Gervais, MD, Nathalie Gachard, PhD, Agnès Guerci, MD PhD, Pierre Fenaux, MD PhD, Hugues de The, MD PhD

Blood (2016) 128 (22): 2892.

https://doi.org/10.1182/blood.V128.22.2892.2892

Published: 2016

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

David Guenat, Carmelo Rizzari, MD, PhD, Patrick Edery, MD, PhD, Jean Soulier, MD, PhD, Christophe Ferrand, PhD, Christophe Borg, MD, PhD, Pierre-Simon Rohrlich, MD, PhD

Blood (2013) 122 (21): 4898.

https://doi.org/10.1182/blood.V122.21.4898.4898

Published: 2013

Journal Articles

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

Blood (2013) 122 (14): 2477–2486.

https://doi.org/10.1182/blood-2013-03-491415

Published: 2013

Includes: Supplemental data

Journal Articles

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

Blood (2013) 121 (5): 822–829.

https://doi.org/10.1182/blood-2012-08-447367

Published: 2013

Includes: Supplemental data

Journal Articles

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation

Fabrice Larosa, Eric Deconinck, Philippe Helias, Jean Fontan, Marian Heczko, Annie Brion, Katell Ledu, Philippe Delaby, Jacqueline Vuiller, Christophe Ferrand, Philippe Saas, Fabienne Pouthier, Anne Dormoy, Jacqueline Chabod, Caroline Malugani, Pierre S. Rohrlich, Faezeh Legrand

Blood (2011) 118 (2): 476–478.

https://doi.org/10.1182/blood-2011-03-343640

Published: 2011

Journal Articles

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance

Carole Henry, Marina Deschamps, Pierre-Simon Rohrlich, Jean-René Pallandre, Jean-Paul Rémy-Martin, Mary Callanan, Alexandra Traverse-Glehen, Camille GrandClément, Francine Garnache-Ottou, Remy Gressin, Eric Deconinck, Gilles Salles, Eric Robinet, Pierre Tiberghien, Christophe Borg, Christophe Ferrand

Blood (2010) 115 (12): 2420–2429.

https://doi.org/10.1182/blood-2009-06-229112

Published: 2010

Includes: Supplemental data

Journal Articles

Allogeneic Suicide Gene-Modified T Cells (aSGMTC) Are Highly Cytotoxic to Non-Hematopoietic Tumor Cell Lines: Rationale for the Production of a Bank of aSGMTC for the Treatment of Solid Tumors.

Laurent Mailly, Celine Leboeuf, Christophe Ferrand, Pierre Tiberghien, Gaetan Bour, Marc Aprahamian, Michel Doffoel, Philippe Wolf, Thomas Baumert, Eric Robinet

Blood (2009) 114 (22): 2459.

https://doi.org/10.1182/blood.V114.22.2459.2459

Published: 2009

Journal Articles

A New Human CD20 Spliced mRNA as a Potential Molecular Marker for the Follow-up of B-Cell Malignancies.

Marina Deschamps, Carole Henry, Eric Robinet, Francine Garnache-Ottou, Jean-Paul Remy-Martin, Christophe Borg, Pierre-Simon Rohrlich, Eric Deconinck, Pierre Tiberghien, Christophe Ferrand

Blood (2008) 112 (11): 1479.

https://doi.org/10.1182/blood.V112.11.1479.1479

Published: 2008

Journal Articles

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft

Marina Deschamps, Patricia Mercier-Lethondal, Jean Marie Certoux, Carole Henry, Bruno Lioure, Céline Pagneux, Jean Yves Cahn, Eric Deconinck, Eric Robinet, Pierre Tiberghien, Christophe Ferrand

Blood (2007) 110 (12): 3842–3852.

https://doi.org/10.1182/blood-2007-04-087346

Published: 2007

Includes: Supplemental data

Journal Articles

A Large Majority of Donor NeoR-Expressing Gene Modified T-Cells Circulating More Than 9 Years after Infusion with allo-BMT, and Capable of Being In-Vitro Expanded and Cloned, Contain a Large Deletion of the HS-tk Gene and Arise from One T-Cell Clone in Each Patient.

Marina Deschamps, Patricia Mercier, Céline Pagneux, Jean-Marie Certoux, Eric Deconinck, MD, PhD, Eric Robinet, PhD, Pierre Tiberghien, MD, PhD, Christophe Ferrand, PhD

Blood (2006) 108 (11): 201.

https://doi.org/10.1182/blood.V108.11.201.201

Published: 2006

Journal Articles

Transgene Deletions in Long-Term Circulating Donor Gene-Modified T Lymphocytes Infused at Time of Hematopoietic Transplantation.

Patricia Mercier, BSc, Marina Deschamps, BSc, Christophe Ferrand, PhD, Eric Robinet, PhD, Jean-Marie Certoux, BSc, Delphine Sauce, PhD, Bruno Lioure, MD, Eric Deconinck, MD, PhD, Pierre Tiberghien, MD, PhD

Blood (2005) 106 (11): 461.

https://doi.org/10.1182/blood.V106.11.461.461

Published: 2005

Journal Articles

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

Blood (2005) 105 (3): 1256–1264.

https://doi.org/10.1182/blood-2004-06-2416

Published: 2005

Journal Articles

Activated and Expanded T Cells for Potential Therapy of Patients with Autoimmune Diseases.

Alice Long, PhD, Mark Bonyhadi, PhD, Christophe Ferrand, PhD, Mark Frohlich, MD, Ronald J. Berenson, MD

Blood (2004) 104 (11): 3854.

https://doi.org/10.1182/blood.V104.11.3854.3854

Published: 2004

NARROW

IL-1RAP Is a Targetable Surface Antigen in Relapsed/Refractoy AML

Resolve AML 001: An Adaptive Open-Label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of Cctx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients with r/r AML

A Fast and Accurate Cartridge-Based RT-qPCR Assay to Quantify PML-Rara mRNA Fusion Transcripts Near the Point of Care

Dynamic of Telomeric Parameters in Relapsing or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL), an Analysis of the Filo ICLL001 Bomp Trial

Optimal Whole Blood Storage Conditions for Measuring BCR-ABL1 Accurately for Xpert ® BCR-ABL Ultra

Xpert ® BCR-ABL Ultra, a High Sensitivity Assay, Demonstrates a Limit of Detection Reaching MR4.5 and below

Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance

Allogeneic Suicide Gene-Modified T Cells (aSGMTC) Are Highly Cytotoxic to Non-Hematopoietic Tumor Cell Lines: Rationale for the Production of a Bank of aSGMTC for the Treatment of Solid Tumors.

A New Human CD20 Spliced mRNA as a Potential Molecular Marker for the Follow-up of B-Cell Malignancies.

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft

A Large Majority of Donor NeoR-Expressing Gene Modified T-Cells Circulating More Than 9 Years after Infusion with allo-BMT, and Capable of Being In-Vitro Expanded and Cloned, Contain a Large Deletion of the HS-tk Gene and Arise from One T-Cell Clone in Each Patient.

Transgene Deletions in Long-Term Circulating Donor Gene-Modified T Lymphocytes Infused at Time of Hematopoietic Transplantation.

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

Activated and Expanded T Cells for Potential Therapy of Patients with Autoimmune Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only